GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a major focus in healthcare investigation, largely due to its notable impact on controlling diseases such as second type diabetes and obesity. Ongoing research have revealed that beyond glucose control, GLP-1 medicatio